Cost–effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.5.5.603 ◽

2005 ◽

Vol 5 (5) ◽

pp. 603-623

Author(s):

Grant H Skrepnek

Keyword(s):

Cost Effectiveness ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Download Full-text

The Cost-effectiveness of HMG-CoA Reductase Inhibitors to Prevent Coronary Heart Disease

JAMA ◽

10.1001/jama.1995.03520370074040 ◽

1995 ◽

Vol 273 (13) ◽

pp. 1032 ◽

Author(s):

Vivian H. Hamilton

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cost Effectiveness ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Coa Reductase ◽

Download Full-text

PCV22: COST-EFFECTIVENESS OF HMG-CoA REDUCTASE INHIBITORS AND FIBRATES THERAPY IN ELDERLY WOMEN WITH CORONARY ARTERY DISEASE

Value in Health ◽

10.1016/s1098-3015(11)70675-1 ◽

2000 ◽

Vol 3 (5) ◽

pp. 318

Author(s):

LB Lazebnik ◽

MJ Kadiskaya

Keyword(s):

Coronary Artery Disease ◽

Cost Effectiveness ◽

Coronary Artery ◽

Elderly Women ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Artery Disease ◽

Download Full-text

Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction

American Journal of Health-System Pharmacy ◽

10.1093/ajhp/56.17.1726 ◽

1999 ◽

Vol 56 (17) ◽

pp. 1726-1732 ◽

Author(s):

William J. Elliott ◽

David R. Weir

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Hmg Coa Reductase ◽

Comparative Cost ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Download Full-text

Cost Effectiveness of Treatment to National Cholesterol Education Panel (NCEP) Targets with HMG-CoA Reductase Inhibitors

PharmacoEconomics ◽

10.2165/00019053-199712020-00018 ◽

1997 ◽

Vol 12 (2) ◽

pp. 278-285 ◽

Author(s):

Donald Black ◽

Michael Davidson ◽

Michael Koren ◽

Rebecca Bakker-Arkema ◽

Perry Tresh ◽

...

Keyword(s):

Cost Effectiveness ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

National Cholesterol Education Panel ◽

Download Full-text

The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C

JAMA ◽

10.1001/jama.273.13.1032 ◽

1995 ◽

Vol 273 (13) ◽

pp. 1032-1038 ◽

Author(s):

V. H. Hamilton

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cost Effectiveness ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Coa Reductase ◽

Download Full-text

A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia

Cardiovascular Drugs and Therapy ◽

10.1007/bf00053037 ◽

1997 ◽

Vol 10 (6) ◽

pp. 787-794 ◽

Author(s):

Sylvie Perreault ◽

Vivian H. Hamilton ◽

Fr�d�ric Lavoie ◽

Steven Grover

Keyword(s):

Cost Effectiveness ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Different Types ◽

Hmg Coa Reductase Inhibitors ◽

Primary Hyperlipidemia ◽

Coa Reductase ◽

Download Full-text

PCV35: COST EFFECTIVENESS ANALYSIS OF HMG-COA REDUCTASE INHIBITORS IN A MEDICAID POPULATION

Value in Health ◽

10.1016/s1098-3015(10)64149-6 ◽

2003 ◽

Vol 6 (3) ◽

pp. 319-320

Author(s):

EA MacLean ◽

CM Moffitt

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Effectiveness Analysis ◽

Medicaid Population ◽

Hmg Coa Reductase Inhibitors ◽

Download Full-text

Cost Effectiveness of HMG-CoA Reductase Inhibitors in the Management of Coronary Artery Disease

American Journal of Cardiovascular Drugs ◽

10.2165/00129784-200303030-00004 ◽

2003 ◽

Vol 3 (3) ◽

pp. 179-191 ◽

Author(s):

Chris McCabe

Keyword(s):

Coronary Artery Disease ◽

Cost Effectiveness ◽

Coronary Artery ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Artery Disease ◽

Download Full-text

Use of HMG-CoA Reductase Inhibitors Is Associated With Lower Plasma Interleukin-6 Levels and a Favourable Cardiac Course in Unstable Angina

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)85097-8 ◽

1998 ◽

Vol 31 (2) ◽

pp. 318A

Author(s):

P Verheggen

Keyword(s):

Unstable Angina ◽

Interleukin 6 ◽

Lower Plasma ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Download Full-text

Similarity of molecular electrostatic potential distributions in a series of HMG-CoA reductase inhibitors. Preliminary results

Journal de Chimie Physique ◽

10.1051/jcp/1991882639 ◽

1991 ◽

Vol 88 ◽

pp. 2639-2644 ◽

Author(s):

U Cosentino ◽

G Moro ◽

D Pitea

Keyword(s):

Electrostatic Potential ◽

Molecular Electrostatic Potential ◽

Hmg Coa Reductase ◽

Preliminary Results ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Download Full-text